Business Wire India Revenue for the Pharmaceuticals grows by 29% in FY22, with strong expansion in Gross Margins PAT up 25% YoY Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the quarter and full year ended March 31, 2022. Financial Highlights: Particulars (INR Crore) FY22 FY21 YoY Revenue 279.39 231.33 +20.8% Gross Profit 83.79 59.19 +41.6% […]
Olectra Greentech has received upgradation in credit ratings from ICRA as under: Long Term Cash Credit (Rs 60 crore)- ICRA A-; Stable Long Term/ Short Term Non-fund Based (Rs 265 crore)- ICRA A-; Stable/ ICRA A2+; Stable Short Term Non-fund Based, Derivative Limits (Rs 5 crore) – ICRA A2+ Short Term Non-Fund Based, Letter of Credit (Rs 170 crore) – ICRA A2+Powered by Capital Market […]
Sales rise 101.03% to Rs 5.85 crore
Sales rise 1.38% to Rs 987.40 crore
Sadhana Nitro Chem announced that the Board of Directors of the Company at its meeting held on 24 May 2022 inter alia have recommended the final dividend of Rs 015 per equity Share ie 15Percentage subject to the approval of the shareholders

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.